Cited by 269Antifungal resistance and susceptibilityFungal and yeast genetics researchYeasts and Rust Fungi Studies

The DOI matches its Crossref record; 155 of the 155 references it cites were found in a registry or an index.

Candida glabrata: a review of its features and resistance

Open access

Rodrigues, C. F., Silva, S., Henriques, M.·2014·European Journal of Clinical Microbiology & Infectious Diseases

DOI 10.1007/s10096-013-2009-3

Open this paper in CoChat — free account

Abstract

Candida species belong to the normal microbiota of the oral cavity and gastrointestinal and vaginal tracts, and are responsible for several clinical manifestations, from mucocutaneous overgrowth to bloodstream infections. Once believed to be non-pathogenic, Candida glabrata was rapidly blamable for many human diseases. Year after year, these pathological circumstances are more recurrent and problematic to treat, especially when patients reveal any level of immunosuppression. These difficulties arise from the capacity of C. glabrata to form biofilms and also from its high resistance to traditional antifungal therapies. Thus, this review intends to present an excerpt of the biology, epidemiology, and pathology of C. glabrata, and detail an approach to its resistance mechanisms based on studies carried out up to the present.

Integrity signals

Registry

Crossref · 10.1007/s10096-013-2009-3

Cites

155 of 155 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem
Pfaller, M. A., & Diekema, D. J. (2007) · Clinical Microbiology Reviews · doi:10.1128/cmr.00029-06 · Cited by 4,174 · cited 1×
“17 different Candida species are known to be etiological agents of human infections; however, more than 90 % of invasive infections are due to Candida species [5].”
Mechanisms of biofilm resistance to antimicrobial agents
Mah, T.-F. C., & O'Toole, G. A. (2001) · Trends in Microbiology · doi:10.1016/s0966-842x(00)01913-2 · Cited by 3,921
International Study of the Prevalence and Outcomes of Infection in Intensive Care Units
Vincent, J. (2009) · JAMA · doi:10.1001/jama.2009.1754 · Cited by 3,639
How long do nosocomial pathogens persist on inanimate surfaces? A systematic review
Krämer, A., Schwebke, I., & Kampf, G. (2006) · BMC Infectious Diseases · doi:10.1186/1471-2334-6-130 · Cited by 2,508
Autophagosome formation: core machinery and adaptations
Xie, Z., & Klionsky, D. J. (2007) · Nature Cell Biology · doi:10.1038/ncb1007-1102 · Cited by 2,237
Persister cells
Lewis, K. (2010) · Annual Review of Microbiology · doi:10.1146/annurev.micro.112408.134306 · Cited by 1,858
Molecular evidence for an ancient duplication of the entire yeast genome
Wolfe, K. H., & Shields, D. C. (1997) · Nature · doi:10.1038/42711 · Cited by 1,785
HOW NEUTROPHILS KILL MICROBES
Segal, A. W. (2005) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115653 · Cited by 1,783
Genome evolution in yeasts
Dujon, B., Sherman, D., Fischer, G., Durrens, P., Casaregola, S., Lafontaine, I., de Montigny, J., Marck, C., Neuvéglise, C., Talla, E., et al. (2004) · Nature · doi:10.1038/nature02579 · Cited by 1,623
Biofilm Formation by the Fungal Pathogen Candida albicans : Development, Architecture, and Drug Resistance
Chandra, J., Kuhn, D. M., Mukherjee, P. K., Hoyer, L. L., McCormick, T., & Ghannoum, M. A. (2001) · Journal of Bacteriology · doi:10.1128/jb.183.18.5385-5394.2001 · Cited by 1,578

Flagged first, then by citations

Show all 155 references

Research works printed but not linked: 1

Helmerhorst EJ, Oppenheim FG (2004) The antifungal mechanisms of antimicrobial proteins. In: Hancock REW, Devine D (eds) Mammalian antimicrobial proteins, 1st edn. Cambridge University Press, Cambridge, pp 245–277

Sorted by citations

Items 101–200 of 269

A Real-Time PCR Assay Based on 5.8S rRNA Gene (5.8S rDNA) for Rapid Detection of Candida from Whole Blood Samples
Guo, Y., Yang, J.-X., & Liang, G. (2015) · Mycopathologia · doi:10.1007/s11046-015-9977-z · Cited by 19
The influence of diet on gastrointestinal Candida spp. colonization and the susceptibility of Candida spp. to antifungal drugs
Jeziorek, M., Frej−Mądrzak, M., & Choroszy−Król, I. (2019) · Roczniki Państwowego Zakładu Higieny · doi:10.32394/rpzh.2019.0070 · Cited by 19
Genome-wide piggyBac transposon-based mutagenesis and quantitative insertion-site analysis in haploid Candida species
Li, Z., Wang, H., Cai, C., Wong, A. H., Wang, J., Gao, J., & Wang, Y. (2020) · Nature Protocols · doi:10.1038/s41596-020-0351-3 · Cited by 18
Current recommendations and importance of antifungal stewardship for the management of invasive candidiasis
Miyazaki, T., & Kohno, S. (2015) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.2015.1058157 · Cited by 18
Prevalence and Antifungal Susceptibility of the Emerging Fungal Species, Candida nivariensis , Isolated in a Teaching Hospital in Poland
Sikora, M., Kuthan, R., Piskorska, K., Gołaś-Prądzyńska, M., Domański, D., AUGUSTYNOWICZ-KOPEĆ, E. M., & Swoboda‐Kopeć, E. (2019) · Polish Journal of Microbiology · doi:10.33073/pjm-2019-032 · Cited by 18
New Aspects of Invasive Growth Regulation Identified by Functional Profiling of MAPK Pathway Targets in Saccharomyces cerevisiae
Vandermeulen, M. D., & Cullen, P. J. (2020) · Genetics · doi:10.1534/genetics.120.303369 · Cited by 18
Early‐Onset Candida glabrata Interface Keratitis after Deep Anterior Lamellar Keratoplasty
Le, Q., Wu, D., Li, Y., Ji, J., Cai, R., & Xu, J. (2015) · Optometry and Vision Science · doi:10.1097/opx.0000000000000565 · Cited by 18
Identification of Components of the SUMOylation Machinery in Candida glabrata
Gujjula, R., Veeraiah, S., Kumar, K., Thakur, S. S., Mishra, K., & Kaur, R. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.706044 · Cited by 18
A New Determinant of Candida glabrata Virulence: The Acetate Exporter CgDtr1
Romão, D., Cavalheiro, M., Mil-Homens, D., Santos, R., Pais, P., Costa, C., Takahashi‐Nakaguchi, A., Fialho, A., Chibana, H., & Teixeira, M. C. (2017) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2017.00473 · Cited by 19
Synthesis, structural characterization, and prospects for new cobalt (II) complexes with thiocarbamoyl-pyrazoline ligands as promising antifungal agents
Dias, B. B., Dantas, F. G. D. S., Galvão, F., Cupozak-Pinheiro, W. J., Wender, H., Pizzuti, L., Rosa, P. P., Tenório, K. V., Gatto, C. C., Negri, M., et al. (2020) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2020.111277 · Cited by 17
The Candida species that are important for the development of atrophic glossitis in xerostomia patients
Nakamura, S., Okamoto, M. R., Yamamoto, K., Tsurumoto, A., Yoshino, Y., Iwabuchi, H., Saito, I., Maeda, N., & Nakagawa, Y. (2017) · BMC Oral Health · doi:10.1186/s12903-017-0449-3 · Cited by 17
A Review on Molecular Mechanisms of Antifungal Resistance in Candida glabrata : Update and Recent Advances
Lotfali, E., Fattahi, A., Sayyahfar, S., Ghasemi, R., Rabiei, M. M., Fathi, M., Vakili, K. G., Deravi, N., Soheili, A., Toreyhi, H., et al. (2021) · Microbial Drug Resistance · doi:10.1089/mdr.2020.0235 · Cited by 18
Thymoquinone Antifungal Activity against Candida glabrata Oral Isolates from Patients in Intensive Care Units—An In Vitro Study
Nouri, N., Mohammadi, S. R., Beardsley, J., Aslani, P., Ghaffarifar, F., Roudbary, M., & Rodrigues, C. F. (2023) · Metabolites · doi:10.3390/metabo13040580 · Cited by 15
Self-citation
Whole-Genome Sequence Analysis of Candida glabrata Isolates from a Patient with Persistent Fungemia and Determination of the Molecular Mechanisms of Multidrug Resistance
Lim, H. J., Choi, M. J., Byun, S. A., Won, E. J., Park, J.-H., Choi, Y. J., Choi, H., Choi, H.-W., Kee, S., Kim, S. H., et al. (2023) · Journal of Fungi · doi:10.3390/jof9050515 · Cited by 18
Pathogenic Candida species differ in the ability to grow at limiting potassium concentrations
Hušeková, B., Elicharová, H., & Sychrová, H. (2016) · Canadian Journal of Microbiology · doi:10.1139/cjm-2015-0766 · Cited by 16
Reversal of fluconazole resistance induced by a synergistic effect withAcca sellowianainCandida glabratastrains
Machado, G. D. R. M., Pippi, B., Lana, D. F. D., Amaral, A. P. S., Teixeira, M. L., de Souza, K. C. B., & Fuentefría, A. M. (2016) · Pharmaceutical Biology · doi:10.3109/13880209.2016.1158286 · Cited by 16
Proper Sterol Distribution Is Required for Candida albicans Hyphal Formation and Virulence
McCourt, P. C., Liu, H., Parker, J. E., Ebert, C., Donigan, M., Bata, A., Giordano, C., Kelly, S. L., & Nickels, J. T. (2016) · G3 Genes Genomes Genetics · doi:10.1534/g3.116.033969 · Cited by 17
Genome-Wide Response to Drugs and Stress in the Pathogenic Yeast Candida glabrata
Pais, P., Galocha, M., & Teixeira, M. C. (2019) · Progress in molecular and subcellular biology · doi:10.1007/978-3-030-13035-0_7 · Cited by 17
Phytochemical analysis and mode of action against Candida glabrata of Paeonia emodi extracts
Sharma, A., Singh, S., Tewari, R., Bhatt, V. P., Sharma, J., & Maurya, I. K. (2018) · Journal de Mycologie Médicale · doi:10.1016/j.mycmed.2018.04.008 · Cited by 15
Quantitative Simulations Predict Treatment Strategies Against Fungal Infections in Virtual Neutropenic Patients
Timme, S., Lehnert, T., Prauße, M. T. E., Hünniger, K., Leonhardt, I., Kurzai, O., & Figge, M. T. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00667 · Cited by 15
Treatment of vaginitis caused by non-albicans Candida species
Sobel, J. D. (2024) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2024.2347953 · Cited by 14
Sodium houttuyfonate enhances the mono-therapy of fluconazole on oropharyngeal candidiasis (OPC) through HIF-1α/IL-17 axis by inhibiting cAMP mediated filamentation in Candida albicans-Candida glabrata dual biofilms
Chen, M., Cheng, T., Xu, C., Pan, M., Wu, J., Wang, T., Wu, D., Yan, G., Wang, C., & Shao, J. (2022) · Virulence · doi:10.1080/21505594.2022.2035066 · Cited by 14
Lab-scale preparations of Candida albicans and dual Candida albicans–Candida glabrata biofilms on the surface of medical-grade polyvinyl chloride (PVC) perfusion tube using a modified gravity-supported free-flow biofilm incubator (GS-FFBI)
Shao, J., Lu, K.-Q., Tian, G., Cui, Y., Yan, Y., Wang, T., Zhang, X., & Wang, C. (2014) · Journal of Microbiological Methods · doi:10.1016/j.mimet.2014.12.006 · Cited by 14
Enhanced Solubility and Bioavailability of Clotrimazole in Aqueous Solutions with Hydrophobized Hyperbranched Polyglycidol for Improved Antifungal Activity
Jaworska‐Krych, D., Gosecka, M., Gosecki, M., Urbaniak, M., Dzitko, K., Ciesielska, A., Wielgus, E., Kadłubowski, S., & Kozanecki, M. (2024) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.3c19388 · Cited by 13
Serotonin reuptake inhibitors effect on fluconazole activity against resistant Candida glabrata strains
Alkhalifa, B. A., Bulatova, N., abuRokba, W., & Darwish, R. M. (2022) · Journal of Global Antimicrobial Resistance · doi:10.1016/j.jgar.2022.01.030 · Cited by 13
Evaluation of four calcium channel blockers as fluconazole resistance inhibitors in Candida glabrata
Al-Najjar, L. M., Bulatova, N., & Darwish, R. M. (2018) · Journal of Global Antimicrobial Resistance · doi:10.1016/j.jgar.2018.04.004 · Cited by 13
Prevalence of human pathogens of the clade Nakaseomyces in a culture collection—the first report on Candida bracarensis in Poland
Małek, M., Mrowiec, P., Klesiewicz, K., Skiba‐Kurek, I., Szczepański, A., Białecka, J., Żak, I., Bogusz, B., Kędzierska, J., Budak, A., et al. (2018) · Folia Microbiologica · doi:10.1007/s12223-018-0655-7 · Cited by 13
Comparative effects of hypoxia and hypoxia mimetic cobalt chloride on in vitro adhesion, biofilm formation and susceptibility to amphotericin B of Candida glabrata
Gupta, P., Nath, S., Meena, R. C., & Kumar, N. (2014) · Journal de Mycologie Médicale · doi:10.1016/j.mycmed.2014.08.003 · Cited by 13
Partial Decay of Thiamine Signal Transduction Pathway Alters Growth Properties of Candida glabrata
Iosue, C. L., Attanasio, N., Shaik, N. F., Neal, E. M., Leone, S. G., Cali, B. J., Peel, M. T., Grannas, A. M., & Wykoff, D. D. (2016) · PLoS ONE · doi:10.1371/journal.pone.0152042 · Cited by 12
Initial Treatment of Cancer Patients with Fluconazole-Susceptible Dose-Dependent Candida glabrata Fungemia: Better Outcome with an Echinocandin or Polyene Compared to an Azole?
Le, A., Farmakiotis, D., Tarrand, J. J., & Kontoyiannis, D. P. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00631-17 · Cited by 12
Trk1-mediated potassium uptake contributes to cell-surface properties and virulence of Candida glabrata
Llopis-Torregrosa, V., Vaz, C., Monteoliva, L., Ryman, K., Engström, Y., Gácser, A., Gil, C., Ljungdahl, P. O., & Sychrová, H. (2019) · Scientific Reports · doi:10.1038/s41598-019-43912-1 · Cited by 11
High throughput comparative assessment of biofilm formation of Candida glabrata on polystyrene material
Sadanandan, B., Ashrit, P., Nataraj, L. K., Shetty, K., Jogalekar, A. P., Vijayalakshmi, V., & Hemanth, B. (2022) · Korean Journal of Chemical Engineering · doi:10.1007/s11814-021-1054-3 · Cited by 11
Invasive candidiasis in non neutropenic critically ill - need for region-specific management guidelines
Baronia, A. K., & Marak, R. S. K. (2015) · Indian Journal of Critical Care Medicine · doi:10.4103/0972-5229.158273 · Cited by 12
A copper(II)-binding triazole derivative with ionophore properties is active against Candida spp.
Gaspar‐Cordeiro, A., da Silva, S. M., Aguiar, M. M., Rodrigues‐Pousada, C., Haas, H., Lima, L. M. P., & Pimentel, C. (2020) · JBIC Journal of Biological Inorganic Chemistry · doi:10.1007/s00775-020-01828-6 · Cited by 11
Self-citation
Molecular epidemiology and antimicrobial resistance of vaginal Candida glabrata isolates in Namibia
Dunaiski, C. M., Kock, M. M., Chan, W. Y., Ismail, A., & Peters, R. P. H. (2024) · Medical Mycology · doi:10.1093/mmy/myae009 · Cited by 11
Zinc oxide nanoparticle inhibits the biofilm formation of Candida glabrata: a sustainable approach to use an agro-waste of cashew apple juice
Anitha, R., Singaravel, V., & Vinoth, J. (2022) · Biomass Conversion and Biorefinery · doi:10.1007/s13399-022-03663-y · Cited by 10
Detection of Echinocandin-Resistant Candida glabrata in Blood Cultures Spiked with Different Percentages of FKS2 Mutants
Bordallo-Cardona, M. Á., Sánchez‐Carrillo, C., Bouza, E., Muñóz, P., Escribano, P., & Guinea, J. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02004-18 · Cited by 10
FLO8 deletion leads to decreased adhesion and virulence with downregulated expression of EPA1, EPA6, and EPA7 in Candida glabrata
Zhao, J.-T., Chen, K.-Z., Liu, J.-Y., Li, W.-H., Wang, Y.-Z., Wang, L.-L., & Xiang, M.-J. (2022) · Brazilian Journal of Microbiology · doi:10.1007/s42770-022-00703-7 · Cited by 9
Blunted blades: new CRISPR-derived technologies to dissect microbial multi-drug resistance and biofilm formation
Gager, C., & Flores‐Mireles, A. L. (2024) · mSphere · doi:10.1128/msphere.00642-23 · Cited by 8
Spectrum of activity and mechanisms of azole–bisphosphonate synergy in pathogenic Candida
Kane, A., Dinh, H., Campbell, L. T., Cain, A. K., Hibbs, D. E., & Carter, D. A. (2024) · Microbiology Spectrum · doi:10.1128/spectrum.00121-24 · Cited by 9
Antibiofilm Activity of PDMS/TiO2 against Candida glabrata through Inhibited Hydrophobic Recovery
Nguyen, K., Sao, L., Kyllo, K., Hernandez, D., Salomon, S., Shah, K., Oh, D., & Kao, K. C. (2024) · ACS Omega · doi:10.1021/acsomega.4c07869 · Cited by 9
Investigation of antifungal and antibiofilm activities of green synthesized silver nanoparticles against Candida glabrata
Ahamad, I., & Fatma, T. (2025) · BioMetals · doi:10.1007/s10534-025-00680-y · Cited by 9
Detection and Quantification of Fluconazole Within Candida glabrata Biofilms
Rodrigues, C. F., Silva, S. M., Azeredo, J., & Henriques, M. (2015) · Mycopathologia · doi:10.1007/s11046-015-9862-9 · Cited by 9
Self-citation
Expression of ERG11 and efflux pump genes CDR1, CDR2 and SNQ2 in voriconazole susceptible and resistant Candida glabrata strains
Navarro-Rodríguez, P., Martín‐Vicente, A., López‐Fernández, L., Guarro, J., & Capilla, J. (2019) · Medical Mycology · doi:10.1093/mmy/myz014 · Cited by 10
Candida glabrata hospital isolate from Lebanon reveals micafungin resistance associated with increased chitin and resistance to a cell-surface-disrupting agent
Fattouh, N., Khalaf, R. A., & Husni, R. (2024) · Journal of Global Antimicrobial Resistance · doi:10.1016/j.jgar.2024.02.012 · Cited by 10
Candida glabrata candidemia
Chakrabarti, A. (2015) · Indian Journal of Critical Care Medicine · doi:10.4103/0972-5229.152753 · Cited by 8
Epidemiological Attributes of Candida Species in Tropical Regions
Bohner, F., Gácser, A., & Tóth, R. (2021) · Current Tropical Medicine Reports · doi:10.1007/s40475-021-00226-5 · Cited by 10
Oceanapiside, a Marine Natural Product, Targets the Sphingolipid Pathway of Fluconazole-Resistant Candida glabrata
Dalisay, D. S., Rogers, E. W., & Molinski, T. F. (2021) · Marine Drugs · doi:10.3390/md19030126 · Cited by 9
Combination therapy against human infections caused by Candida species
Maurya, I. K., Semwal, R. B., & Semwal, D. K. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-820576-1.00004-7 · Cited by 11
Decoding the role of oxidative stress resistance and alternative carbon substrate assimilation in the mature biofilm growth mode of Candida glabrata
Raj, K., Paul, D., Rishi, P., Shukla, G., Dhotre, D. P., & YogeshSouche (2024) · BMC Microbiology · doi:10.1186/s12866-024-03274-9 · Cited by 8
In Vitro Assessment of Fluconazole and Cyclosporine A Antifungal Activities: A Promising Drug Combination Against Different Candida Species
Cartón, J. D., de la Fuente, I., Sevillano, E., Jauregizar, N., Quindós, G., Eraso, E., & Guridi, A. (2025) · Journal of Fungi · doi:10.3390/jof11020133 · Cited by 9
Epidemiology and susceptibility of Nakaseomyces (formerly Candida) glabrata bloodstream isolates from hospitalised adults in South Africa
Naicker, S. D., Shuping, L., Zulu, T. G., Mpembe, R. S., Mhlanga, M., Tsotetsi, E., Maphanga, T. G., Govender, N. P., MMed, F. P. S., Black, J., et al. (2023) · Medical Mycology · doi:10.1093/mmy/myad057 · Cited by 9
Two promising Bacillus-derived antifungal lipopeptide leads AF4 and AF5 and their combined effect with fluconazole on the in vitro Candida glabrata biofilms
Madhuri, M., Rudramurthy, S. M., & Roy, U. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1334419 · Cited by 8
Candida albicans bloodstream isolates in a German university hospital are genetically heterogenous and susceptible to commonly used antifungals
Huyke, J., Martin, R., Walther, G., Weber, M., Kaerger, K., Bougnoux, M., Elias, J., & Kurzai, O. (2015) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2015.08.027 · Cited by 8
Limosilactobacillus reuteri 29A Cell-Free Supernatant Antibiofilm and Antagonistic Effects in Murine Model of Vulvovaginal Candidiasis
Boahen, A., Chew, S. Y., Neela, V. K., & Than, L. T. L. (2023) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-023-10050-0 · Cited by 10
Anti-Candidal Activity of the Parasitic Plant Orobanche crenata Forssk
D’Angeli, F., Guadagni, F., Genovese, C., Nicolosi, D., Salinaro, A. T., Spampinato, M., Mannino, G., Furno, D. L., Petronio, G. P., Ronsisvalle, S., et al. (2021) · Antibiotics · doi:10.3390/antibiotics10111373 · Cited by 9
Whole Genome Analysis of Echinocandin Non‐Susceptible Candida Glabrata Clinical Isolates: a Multi‐Center Study in China
Li, Y., Hou, X., Li, R., Liao, K., Ma, L., Wang, X., Ji, P., Kong, H., Xia, Y., Ding, H., et al. (2023) · BMC Microbiology · doi:10.1186/s12866-023-03105-3 · Cited by 7
Two promising natural lipopeptides from Bacillus subtilis effectively induced membrane permeabilization in Candida glabrata
Madduri, M., Rudramurthy, S. M., & Roy, U. (2024) · Acta Biochimica Polonica · doi:10.3389/abp.2024.11999 · Cited by 7
Characterization of the Secretome of Pathogenic Candida glabrata and Their Effectiveness against Systemic Candidiasis in BALB/c Mice for Vaccine Development
Kamli, M. R., Sabir, J. S. M., Malik, M. A., & Ahmad, A. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14101989 · Cited by 7
Evaluation of antifungal activity of hemolymph of American cockroaches against three human invasive fungal species: Aspergillus niger, Candida albicans and Penicillium oxalicum
Zahirnia, A. H., Seifi-Kar, M., & Nasirian, H. (2023) · International Journal of Tropical Insect Science · doi:10.1007/s42690-023-01056-w · Cited by 7
Functional analysis of selected deletion mutants in Candida glabrata under hypoxia
Gupta, P., Meena, R. C., & Kumar, N. (2017) · 3 Biotech · doi:10.1007/s13205-017-0821-7 · Cited by 8
Isolated Cutaneous Granuloma Caused by Candida glabrata: A Rare Case Report and Literature Review
Fan, Y., Pan, W., Wang, G., Huang, Y., Li, Y., Fang, W. Y., & Tao, X. (2017) · Mycopathologia · doi:10.1007/s11046-017-0228-3 · Cited by 7
Multidrug-resistant Candida glabrata strains obtained by induction of anidulafungin resistance in planktonic and biofilm cells
Hatwig, C., Balbueno, E. A., Bergamo, V. Z., Pippi, B., Fuentefria, A. M., & Silveira, G. P. (2019) · Brazilian Journal of Pharmaceutical Sciences · doi:10.1590/s2175-97902019000218025 · Cited by 6
Vulvovaginal candidiasis and antifungal susceptibility pattern of isolated Candida spp. among women in Aden Governorate, Yemen
Gubran, A. N. M., Al-Baghdadi, M. A. A., & Al-Haidary, N. M. (2026) · BMC Infectious Diseases · doi:10.1186/s12879-025-12471-4 · Cited by 6
Cytological Diagnosis of Infectious Diseases: Identification of Pathogens and Recognition of Cellular Reactions
Tsutsumi, Y. (2021) · IntechOpen eBooks · doi:10.5772/intechopen.95578 · Cited by 6
Vaginal candidiasis in Konya area: Etiology, risk factors, virulence patterns, and antifungal susceptibility
Tokak, S., Kılıç, İ. H., Horasanlı, J. E., MUTLU, E. G., Taşbent, F. E., & Karagöz, I. D. (2021) · Revista română de medicină de laborator · doi:10.2478/rrlm-2021-0012 · Cited by 6
Mucocutaneous Candida Infections in Immunocompromised Patients
Chahine, A., Farooqi, S., Marzvanyan, A., Michael, M., Chavez-Frazier, A., & Guzman, N. (2022) · Current Dermatology Reports · doi:10.1007/s13671-022-00356-7 · Cited by 6
Comparative Evaluation of a New Commercial Colorimetric Microdilution Assay (SensiQuattro Candida EU) with MIC Test Strip and EUCAST Broth Microdilution Methods for Susceptibility Testing of Invasive Candida Isolates
Köhling, H.-L., Willinger, B., Buer, J., Rath, P., & Steinmann, J. (2014) · Journal of Clinical Microbiology · doi:10.1128/jcm.02830-14 · Cited by 6
The phosphorelay signal transduction system in Candida glabrata: an in silico analysis
Carapia-Minero, N., Castelán-Vega, J. A., Pérez, N. O., & Rodríguez-Tovar, A. V. (2017) · Journal of Molecular Modeling · doi:10.1007/s00894-017-3545-z · Cited by 7
Recurrent Vulvovaginal Infections: Etiology, Diagnosis, Treatment and Management
Singh, J., Kalia, N., & Kaur, M. (2018) · Springer eBooks · doi:10.1007/978-981-13-1577-0_14 · Cited by 7
Artemisia annua and artemisinins are ineffective against human Babesia microti and six Candida sp
Elfawal, M. A., Gray, O., Dickson-Burke, C., Weathers, P. J., & Rich, S. M. (2021) · Longhua Chinese Medicine · doi:10.21037/lcm-21-2 · Cited by 6
Agrobacterium tumefaciens-Mediated Transformation of Candida glabrata
D'Spain, S. K., Andrade, P. I., Brockman, N. E., Fu, J., & Wickes, B. L. (2022) · Journal of Fungi · doi:10.3390/jof8060596 · Cited by 6
Expanding the toolkit for genetic manipulation and discovery in Candida species using a CRISPR ribonucleoprotein-based approachPreprint
Gregor, J. B., Gutierrez-Schultz, V. A., Hoda, S., Baker, K. M., Saha, D., Burghaze, M. G., & Briggs, S. D. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.06.16.545382 · Cited by 5
Discovery of novel thiosemicarbazone derivatives with potent and selective anti- Candida glabrata activity
Li, X., Li, L., Zhang, H., Chi, X., Jiang, Y., & Ni, T. (2023) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.1080/14756366.2023.2202362 · Cited by 5
Molecular mechanisms of azole resistance in Candida glabrata isolated from oropharyngeal candidiasis in head and neck cancer patients
Hatami, F., Manifar, S., Asghari-Paskiabi, F., Amiri, F. B., Nojoumi, S. A., & Jahanshiri, Z. (2023) · Archives of Oral Biology · doi:10.1016/j.archoralbio.2023.105757 · Cited by 5
Effect of Escin Alone or in Combination with Antifungal Agents on Resistant Candida glabrata Biofilms: Mechanisms of Action
Maione, A., Imparato, M., Galdiero, M., de Alteriis, E., Feola, A., Galdiero, E., & Guida, M. (2023) · Antibiotics · doi:10.3390/antibiotics12071210 · Cited by 6
Adhesive and biofilm‐forming Candida glabrata Lebanese hospital isolates harbour mutations in subtelomeric silencers and adhesins
Fattouh, N., Husni, R., Finianos, M., Bitar, I., & Khalaf, R. A. (2024) · Mycoses · doi:10.1111/myc.13750 · Cited by 5
Biofilms on urban aquatic plastic pollution as a reservoir for pathogenic yeasts
Baker, T., Bester, A., Sebolai, O. M., Albertyn, J., & Pohl, C. H. (2024) · Journal of Water and Health · doi:10.2166/wh.2024.133 · Cited by 5
Molecular Detection of Resistance to Azole Components
Posteraro, B., Vella, A., Carolis, E. D., & Sanguinetti, M. (2016) · Methods in molecular biology · doi:10.1007/978-1-4939-6515-1_24 · Cited by 5
Vaginitis por Candida glabrata: ¿la gran olvidada?
Arroyo-Fajardo, A., Juan-Delgado, M. F. S., & García‐Rodríguez, J. (2017) · Revista Iberoamericana de Micología · doi:10.1016/j.riam.2017.01.001 · Cited by 4
Activity and expression of Candida glabrata vacuolar proteases in autophagy-like conditions
Cortez-Sánchez, J. L., Cortés-Acosta, E., Cueto-Hernández, V. M., Reyes‐Maldonado, E., Hernández, G., Villa‐Tanaca, L., & Ibarra, J. A. (2018) · FEMS Yeast Research · doi:10.1093/femsyr/foy006 · Cited by 5
Glucose supplementation effect on the acidogenicity, viability, and extracellular matrix of Candida single‐ and dual‐species biofilms
Bezerra, N. V. F., Brito, A. C. M., de Medeiros, M. M. D., Leite, K. L. D. F., Bezerra, I. M., de Almeida, L. D. F. D., Aires, C. P., & Cavalcanti, Y. W. (2019) · Journal of Investigative and Clinical Dentistry · doi:10.1111/jicd.12412 · Cited by 6
High Rate of Oral Candida Detection in Dependent Japanese Older People
Matsumura, M., Shigeishi, H., Su, C.-Y., Nishimura, R., Ohta, K., & Sugiyama, M. (2020) · Geriatrics · doi:10.3390/geriatrics5010021 · Cited by 5
Infección del torrente sanguíneo por Candida glabrata en una unidad de cuidados intensivos neonatales con prescripción de profilaxis con fluconazol
Lona-Reyes, J. C., Gómez-Ruiz, L. M., Cordero-Zamora, A., Chávez-Rodríguez, M., Gallegos-Marín, J. A., & Jiménez-Hernández, D. S. (2020) · Revista Iberoamericana de Micología · doi:10.1016/j.riam.2020.06.002 · Cited by 5
CANDIDA DIAGNOSTIC PLATFORMS: ESSENTIAL IN EARLY MANAGEMENT OF CANDIDA INFECTIONS
Hassan, Y., Aminu, I., & Abbdullahi, S. A. (2021) · FUDMA Journal of Sciences · doi:10.33003/fjs-2021-0502-522 · Cited by 5
Induction of Antifungal Tolerance Reveals Genetic and Phenotypic Changes in Candida glabrata
Chedraoui, C., Fattouh, N., Hachem, S. E., Younes, M., & Khalaf, R. A. (2025) · Journal of Fungi · doi:10.3390/jof11040284 · Cited by 4
The Impact of Diabetes Mellitus on Fungal Infections: Pathophysiology, Clinical Manifestations, and Treatment Approaches
Pandey, P., Saha, S., Jakhmola, V., & Kalra, K. (2025) · Journal of Pure and Applied Microbiology · doi:10.22207/jpam.19.2.18 · Cited by 4
Phytochemical composition, antifungal activity, in vitro and in vivo toxicity of Syzygium cumini (L.) Skeels leaves extract
Júnior, E. C. F., Cavalcanti, Y. W., Lira, A. B., Pêssoa, H. D. L. F., Lopes, W. S., Silva, D. R., Freires, I. A., Rosalen, P. L., Costa, E. M. M. D. B., & Pereira, J. V. (2021) · Boletin Latinoamericano y del Caribe de plantas Medicinales y Aromaticas · doi:10.37360/blacpma.21.20.5.40 · Cited by 6
The susceptibility of Candida albicans strains to selected anticancer drugs and flucytosine, relevance of the presence of self-splicing intron in 25S rDNA
Król, J., Nawrot, U., & Bartoszewicz, M. (2018) · Journal de Mycologie Médicale · doi:10.1016/j.mycmed.2018.11.002 · Cited by 4
Recurrent vulvovaginal candidiasis with Candida glabrata – a management conundrum
Taghinejadi, N., Andersson, M. I., & Lord, E. (2022) · International Journal of STD & AIDS · doi:10.1177/09564624221118739 · Cited by 4
A Combination of β-Aescin and Newly Synthesized Alkylamidobetaines as Modern Components Eradicating the Biofilms of Multidrug-Resistant Clinical Strains of Candida glabrata
Paluch, E., Bortkiewicz, O., Widelski, J., Duda-Madej, A., Gleńsk, M., Nawrot, U., Lamch, Ł., Długowska, D., Sobieszczańska, B., & Wilk, K. A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25052541 · Cited by 5
Resistance of Candida glabrata to drugs and the host immune system
Musa, K. B., Ahmed, M. A., Shahpudin, S. N. M., Kamal, L. Z. M., Sandai, R., Tabana, Y., & Sandai, D. A. (2018) · Clinical Microbiology and Infectious Diseases · doi:10.15761/cmid.1000145 · Cited by 4
Emerging Fungal Infections in the Era of Antibiotic Stewardship
Truong, J., Vertees, R., Dietrich, T., Maguire-Rodriguez, J., & Ashurst, J. V. (2019) · Case Reports in Infectious Diseases · doi:10.1155/2019/5963143 · Cited by 4
Clinical and epidemiological aspects of Candida yeast infections and rational use of antifungals
Neto, J. M., Dias, V. C., Bastos, V. Q. D. A., Bastos, L. Q. D. A., Bastos, A. N., Bastos, R. V., da Silva, V. L., Machado, A. B. F., & Diniz, C. G. (2024) · Future Microbiology · doi:10.1080/17460913.2024.2342679 · Cited by 3
Phylogenomic analysis and genetic mechanisms of antifungal resistance in clinical isolates of Candida glabrata ( Nakaseomyces glabratus ) from across Canada, 2013–2020
Luca, D. G. D., Alexander, D. C., Dingle, T. C., Dufresne, P. J., Fuller, J., German, G. J., Haldane, D. J. M., Hoang, L., Jiao, L., Kus, J. V., et al. (2025) · Microbiology Spectrum · doi:10.1128/spectrum.01803-25 · Cited by 3
Critical parameters of fungal pathogenicity at the epithelial interphase
Möslinger, A., Allert, S., Vylkova, S., & Hube, B. (2026) · microLife · doi:10.1093/femsml/uqag001 · Cited by 3
Effects of Storage Temperature and pH on the Antifungal Effects of Commercial Oral Moisturizers against Candida albicans and Candida glabrata
Murakami, M., Harada, K., Nishi, Y., Shimizu, T., Motoyama, S., & Nishimura, M. (2020) · Medicina · doi:10.3390/medicina56100525 · Cited by 4
Niacin Limitation Promotes Candida glabrata Adhesion to Abiotic Surfaces
Li, X., He, L., Krom, B. P., Cheng, L., de Soet, J. J., & Deng, D. (2022) · Pathogens · doi:10.3390/pathogens11040387 · Cited by 4
Effects of biofilm formation and plethora of Candida species causing ailments: a mini review
Aliyu, A. (2022) · Gadau Journal of Pure and Allied Sciences · doi:10.54117/gjpas.v1i2.27 · Cited by 3
Diagnostic usefulness of differential time to positivity in neutropenic cancer patients with suspected catheter-related candidemia
Jo, K. M., Choi, S., Jung, K. H., Park, J. W., Yun, J. H., Kim, M. J., Chong, Y. P., Lee, S., Choi, S., Kim, Y. S., et al. (2019) · Medical Mycology · doi:10.1093/mmy/myz028 · Cited by 3

Authors: Rodrigues, C. F., Silva, S., & Henriques, M.
Affiliations: Institute for Biotechnology and Bioengineering (PT)
Corresponding author: Henriques, M.
ORCID: Rodrigues, C. F.
Silva, S.
Henriques, M.
Venue: European Journal of Clinical Microbiology & Infectious Diseases
Publisher: Springer Science and Business Media LLC
Published: 2013-11-19
Volume: 33
Issue: 5
Pages: 673-688
ISSN: 0934-9723 (ISSN-L)
1435-4373
DOI: 10.1007/s10096-013-2009-3
OpenAlex: W2099290964
Cited by: 268
References: 155
Citations by year: 2026: 11 · 2025: 10 · 2024: 23 · 2023: 17 · 2022: 25 · 2021: 28 · 2020: 27 · 2019: 24 · 2018: 34 · 2017: 24 · 2016: 19 · 2015: 16 · 2014: 10
FWCI: 1.95
Type: journal article
Language: en
Open access: green
hdl.handle.net
Licence: other-oa
www.springer.com/tdm (tdm)
Locations: European Journal of Clinical Microbiology & Infectious Diseases (publishedVersion)
PubMed (publishedVersion)
Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) (submittedVersion, other-oa)
Topics: Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fungal and yeast genetics research
Life Sciences › Immunology and Microbiology › Microbiology › Yeasts and Rust Fungi Studies
Keywords: Candida glabrata, antifungal resistance, biofilm, candidiasis, bloodstream infection, immunosuppression, fungal pathogenesis, yeast biology
MeSH terms: Antifungal Agents, Candidiasis, Humans, Drug Resistance, Fungal, Candida glabrata

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Candida glabrata: a review of its features and resistance

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks